<i>Mycobacterium tuberculosis</i> DprE1 inhibitor——Macozinone

doi:10.3969/j.issn.1672-3384.2022.04.003

PDF(461 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (4) : 11-15. DOI: 10.3969/j.issn.1672-3384.2022.04.003

Comment of new drugs

Mycobacterium tuberculosis DprE1 inhibitor——Macozinone

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(4): 11-15 https://doi.org/10.3969/j.issn.1672-3384.2022.04.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(461 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2021-07-31	2022-05-10
Issue Date
2022-05-10

Please choose a citation manager

Content to export